Skip to content

Clinical study of stellate ganglion block combined with tropisetron in preventing postoperative nausea and vomiting in gynecological laparoscopic patients

Clinical study of stellate ganglion block combined with tropisetron in preventing postoperative nausea and vomiting in gynecological laparoscopic patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078428
Enrollment
Unknown
Registered
2023-12-07
Start date
2021-11-29
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological patients who require laparoscopic surgery

Interventions

Group S:0.5% lidocaine 5mL planetary ganglion block after general anesthesia induction+1mL saline intravenous injection after surgery
Group ST:After induction of general anesthesia, 0.5% lidocaine 5mL planetary ganglion block+intravenous injection of 5mg (1mL) of bitropisetron
Group T:Intravenous injection of 5mg (1mL) of Sabidosetron

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Under the age of 18-65 years old, female in gender, with an ASA rating of I-III; ? At that time, the surgery was laparoscopic oophorectomy or laparoscopic hysterectomy; ? Not receiving radiotherapy or chemotherapy before surgery; ? Stable vital signs and clear language; ? No autoimmune diseases; ? The patient and their family members have informed consent to participate in this experiment and signed an informed consent form.

Exclusion criteria

Exclusion criteria: ? Apply antihistamine or other anti emetic drugs to stop vomiting before surgery; ? SGB contraindications or failure to block; ? Individuals who are allergic to 5-HT3 receptor antagonists; ? Unable to communicate with doctors normally; ? Having severe cardiovascular and cerebrovascular diseases; ? Abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting incidence;Severity of postoperative nausea and vomiting;

Secondary

MeasureTime frame
Postoperative Analgesics Usage;Postoperative use of antiemetic drugs;Postoperative Pain Visual Analog Scale (VAS);Intraoperative systolic blood pressure of patients;Intraoperative diastolic blood pressure of patients;Mean intraoperative arterial pressure of the patient;Patient surgical center rate;Postoperative recovery time;First postoperative exhaust time;Postoperative headache incidence;The incidence of postoperative sleep disorders;Postoperative skin itching incidence;Incidence of postoperative respiratory depression;

Countries

China

Contacts

Public ContactMa Hong

The First Hospital of China Medical University

mahong5466@126.com+86 138 4036 6406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026